Ling Hou

1.5k total citations
69 papers, 736 citations indexed

About

Ling Hou is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Ling Hou has authored 69 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Nephrology. Recurrent topics in Ling Hou's work include Growth Hormone and Insulin-like Growth Factors (14 papers), Renal Diseases and Glomerulopathies (8 papers) and Hypothalamic control of reproductive hormones (7 papers). Ling Hou is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (14 papers), Renal Diseases and Glomerulopathies (8 papers) and Hypothalamic control of reproductive hormones (7 papers). Ling Hou collaborates with scholars based in China, United States and Canada. Ling Hou's co-authors include Xiaoping Luo, Yan Liang, Chengguang Zhao, Yubin Wu, Yanqin Ying, Yue Du, Yan Lü, Pengyuan Liu, Weiguo Lü and Qin Ning and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and Scientific Reports.

In The Last Decade

Ling Hou

63 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Hou China 14 344 149 147 100 89 69 736
Shubin Hong China 15 282 0.8× 211 1.4× 210 1.4× 52 0.5× 34 0.4× 44 650
Shohei Honda Japan 18 430 1.3× 113 0.8× 43 0.3× 93 0.9× 26 0.3× 71 935
S Bertolini Italy 18 252 0.7× 160 1.1× 340 2.3× 100 1.0× 26 0.3× 53 988
Hongmei Peng China 12 216 0.6× 44 0.3× 117 0.8× 31 0.3× 48 0.5× 34 719
Mark Busbridge United Kingdom 18 125 0.4× 61 0.4× 49 0.3× 49 0.5× 65 0.7× 34 1.5k
Panagiotis Flevaris United States 13 378 1.1× 85 0.6× 105 0.7× 54 0.5× 34 0.4× 14 930
Megumi Kanasaki Japan 13 345 1.0× 135 0.9× 281 1.9× 24 0.2× 138 1.6× 27 890
Maria Aminoff Finland 9 397 1.2× 29 0.2× 116 0.8× 105 1.1× 154 1.7× 10 915
Pan Tan China 15 408 1.2× 249 1.7× 59 0.4× 44 0.4× 86 1.0× 20 744
Marcello Filopanti Italy 20 509 1.5× 33 0.2× 458 3.1× 240 2.4× 267 3.0× 41 1.3k

Countries citing papers authored by Ling Hou

Since Specialization
Citations

This map shows the geographic impact of Ling Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Hou more than expected).

Fields of papers citing papers by Ling Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Hou. The network helps show where Ling Hou may publish in the future.

Co-authorship network of co-authors of Ling Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Hou. A scholar is included among the top collaborators of Ling Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Hou. Ling Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Xiaoyu, et al.. (2025). Association of cardiovascular health with COPD (NHANES 2007-2020): mediating potential of lean body mass. Frontiers in Endocrinology. 16. 1539550–1539550. 1 indexed citations
2.
Hou, Ling, et al.. (2024). Knockdown of nicotinamide N-methyltransferase ameliorates renal fibrosis caused by ischemia–reperfusion injury and remodels sphingosine metabolism. Clinical and Experimental Nephrology. 28(12). 1241–1253. 1 indexed citations
3.
Wang, Huanyu, Shimin Wu, Xi Yang, et al.. (2024). Increased serum carboxylesterase-1 levels are associated with metabolic dysfunction associated steatotic liver disease and metabolic syndrome in children with obesity. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 50(1). 162–162. 1 indexed citations
4.
Luo, Xiaoping, Ling Hou, Yan Zhong, et al.. (2024). A Phase 2 Study of PEGylated Recombinant Human Growth Hormone for 52 Weeks in Short Children Born Small for Gestational Age in China. Clinical Endocrinology. 102(2). 136–146.
5.
Hou, Ling & Yue Du. (2023). Neuropilin 1 promotes unilateral ureteral obstruction-induced renal fibrosis via RACK1 in renal tubular epithelial cells. American Journal of Physiology-Renal Physiology. 325(6). F870–F884. 4 indexed citations
6.
Ying, Yanqin, et al.. (2023). Growth Hormone Treatment in Children with Perthes Disease and GrowthHormone Deficiency: A Case Report and Literature Review. Endocrine Metabolic & Immune Disorders - Drug Targets. 23(13). 1668–1673. 1 indexed citations
7.
Luo, Xiaoping, et al.. (2023). Association of size for gestational age and dehydroepiandrosterone sulfate with cardiometabolic risk in central precocious puberty girls. Frontiers in Endocrinology. 14. 1131438–1131438. 2 indexed citations
8.
Lan, Wei, Ling Hou, Yanqin Ying, & Xiao-Ping Luo. (2022). A Novel Missense Mutation in TWNK Gene Causing Perrault Syndrome Type 5 in a Chinese Family and Review of the Literature. SHILAP Revista de lepidopterología. 6 indexed citations
9.
Wu, Wei, Qian Zhou, Xiaoyu Li, et al.. (2022). PEGylated Recombinant Human Growth Hormone Jintrolong® Exhibits Good Long-Term Safety in Cynomolgus Monkeys and Human Pediatric Growth Hormone Deficiency Patients. Frontiers in Endocrinology. 13. 821588–821588. 6 indexed citations
10.
Hou, Ling, et al.. (2022). Study on the relationship between nephrotic syndrome and atopic diseases in childhood. Frontiers in Pediatrics. 10. 992862–992862. 1 indexed citations
11.
Hou, Ling, et al.. (2021). History of pediatric type 1 diabetes in China. Pediatric Diabetes. 23(5). 551–555. 2 indexed citations
12.
13.
Hou, Ling, et al.. (2021). Leflunomide therapy for IgA vasculitis with nephritis in children. BMC Pediatrics. 21(1). 391–391. 5 indexed citations
14.
Hou, Ling, Zhou Zhang, Yue Du, Xiuli Wang, & Chengguang Zhao. (2021). An Allergic Risk Factor Analysis of Extraordinary Daytime Only Urinary Frequency in Children. Risk Management and Healthcare Policy. Volume 14. 2683–2688. 3 indexed citations
15.
16.
Zhang, Lei, Qing Zhou, Qiongzi Qiu, et al.. (2019). CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis in ovarian cancer. Molecular Cancer. 18(1). 144–144. 124 indexed citations
17.
Hou, Ling, Yue Du, Chengguang Zhao, & Yubin Wu. (2018). PAX2 may induce ADAM10 expression in renal tubular epithelial cells and contribute to epithelial-to-mesenchymal transition. International Urology and Nephrology. 50(9). 1729–1741. 13 indexed citations
18.
Xu, Tao, et al.. (2016). Intermittent exercise improves the vasoreactivity of the thoracic aorta in rats. Biomedical Reports. 4(4). 427–432.
19.
Hou, Ling. (2010). Early biomarkers for acute kidney injury. 17(5). 454–456. 1 indexed citations
20.
Liang, Yan, Wei Hong, Jianling Zhang, Ling Hou, & Xiaoping Luo. (2006). Efficacy of subcutaneous administration of gonadotropin-releasing hormone agonist on idiopathic central precocious puberty. Journal of Huazhong University of Science and Technology [Medical Sciences]. 26(5). 558–561. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shubin Hong Breakdown of academic impact, for papers by Shohei Honda Breakdown of academic impact, for papers by S Bertolini Breakdown of academic impact, for papers by Hongmei Peng Breakdown of academic impact, for papers by Mark Busbridge Breakdown of academic impact, for papers by Panagiotis Flevaris Breakdown of academic impact, for papers by Megumi Kanasaki Breakdown of academic impact, for papers by Maria Aminoff Breakdown of academic impact, for papers by Pan Tan Breakdown of academic impact, for papers by Marcello Filopanti
Rankless by CCL
2026